FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

632 letters match. Newest first.

  1. Drivergent, Inc.

    Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.

    High risk
  2. Premier Nutra Pharma Inc.

    FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.

    High risk
  3. Accra-Pac, Inc. dba Voyant Beauty

    Voyant Beauty's Elkhart, Indiana plant made OTC aerosol drugs contaminated with benzene and failed to investigate or test properly.

    High risk
  4. Pharmaplast S.A.E.

    FDA cited Pharmaplast S.A.E. for failing to test drug components, including glycerin and ethanol, for dangerous contaminants.

    High risk
  5. Zermat International S.A. de C.V.

    FDA warns Zermat International about current good manufacturing practice violations for OTC drugs, including releasing out-of-specification lots without investigation.

    High risk
  6. Chemical Services Group, Inc./Royal Chemical Company

    Royal Chemical Company made OTC hand sanitizer on equipment shared with industrial chemicals, and FDA found cleaning, supplier testing and quality unit failures.

    High risk
  7. Eco Lips, Inc.

    FDA warned Eco Lips, Inc. that its over-the-counter sunscreen drug products had serious manufacturing and testing failures.

    High risk
  8. Champaklal Maganlal Homeo Pharmacy Private Limited

    Champaklal Maganlal Homeo Pharmacy failed to test each glycerin lot for identity, including DEG/EG, in OTC and homeopathic drugs.

    High risk
  9. Omega Packaging Corp

    Omega Packaging Corp failed to test hand sanitizer ingredients and validate processes, FDA found.

    High risk
  10. NuGeneration Technologies LLC

    FDA inspected NuGeneration Technologies' Emeryville, California drug plant and found CGMP failures in hand sanitizer release testing, ingredient and water testing, stability and process validation.

    High risk
  11. Cosmetic Science Laboratories LLC

    FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.

    High risk
  12. Dunagin Pharmaceuticals Inc. dba Massco Dental

    Dunagin Pharmaceuticals dba Massco Dental made oral drugs with CGMP violations including shared equipment and inadequate component testing.

    High risk
  13. Formology Lab Inc.

    FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.

    High risk
  14. Midlab Incorporated

    FDA cited Midlab in Athens, Tennessee for manufacturing violations and unapproved, misbranded hand sanitizer and antibacterial soap drugs.

    High risk
  15. Frenda Corporation

    FDA found Frenda made OTC alcohol and hand sanitizer under insanitary conditions with industrial chemical cross-contamination risk.

    High risk
  16. Profounda, Inc.

    FDA warns Profounda about manufacturing quality failures for over-the-counter drugs, including process validation, stability, water system, and glycerin testing.

    High risk
  17. Atlantic Management Resources LTD dba. Claire Ellen Products

    Atlantic Management Resources (Claire Ellen Products) had CGMP violations and distributed unlisted Neuroquell Plus Cream.

    Medium
  18. B & J Group

    B & J Group, a Morrisville, PA contract filler of OTC hand sanitizer, was cited by FDA for skipping finished-product and ingredient testing.

    High risk
  19. Gascó Industrial Corporation

    FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.

    High risk
  20. Skyless, LLC

    FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.

    High risk
  21. Ultra Chem Labs Corporation

    FDA warns Ultra Chem Labs about methanol-tainted hand sanitizer sold as an unapproved, misbranded drug.

    High risk
  22. Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil

    FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.

    High risk
  23. Clean Cosmetics LLC

    FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.

    High risk
  24. Salon Technologies International, Inc.

    FDA warns Salon Technologies International that its hand sanitizers contained unacceptable acetaldehyde, acetal and benzene impurities and were adulterated.

    High risk
  25. Quality Supplement Manufacturing, Inc.

    FDA cited Quality Supplement Manufacturing for dietary supplement manufacturing and labeling violations, including undeclared shellfish allergens.

    High risk
  26. Fei Fah Medical Manufacturing Pte. Ltd.

    FDA warned Fei Fah Medical Manufacturing over inadequate stability data, unvalidated test methods, and supplier testing failures for over-the-counter drugs.

    High risk
  27. Kobayashi Healthcare International, Inc.

    Kobayashi's Georgia plant released Zim's OTC pain drugs without microbial testing and lacked quality unit oversight, FDA says.

    High risk
  28. Mohawk Laboratories Division of NCH Corporation

    FDA warns Mohawk Laboratories that its hand sanitizer contained unacceptable acetaldehyde and acetal impurities.

    High risk
  29. Urban Electric Power

    Urban Electric Power hand sanitizers contained unacceptable acetaldehyde and acetal impurities and had CGMP violations.

    High risk
  30. Buzzagogo, LLC

    Buzzagogo's Allergy Bee Gone for Kids nasal swab is an unapproved new drug contaminated with Bacillus bacteria.

    High risk
  31. Auto-Chlor System LLC

    Auto-Chlor System LLC made hand sanitizer under poor manufacturing practices and sold it as an unapproved, misbranded new drug.

    High risk
  32. Superior Glove Works, Ltd.

    Canada's Superior Glove Works made hand sanitizers with ethanol containing unsafe acetaldehyde levels and skipped required testing, FDA says.

    High risk
  33. Green Pharmaceuticals Inc.

    FDA found Green Pharmaceuticals' SnoreStop NasoSpray contaminated with Providencia rettgeri and sold as an unapproved new drug.

    High risk
  34. MD Pharmaceutical Supply, LLC

    FDA warns MD Pharmaceutical Supply over API repackaging failures, including redistributing a returned lot and uncontrolled cross-contamination risks.

    High risk
  35. Nortec Quimica SA

    FDA warned Brazil's Nortec Quimica, an API maker, over deleted lab data and weak quality unit review of batches exported to the U.S.

    High risk
  36. DuPont Nutrition USA Inc.

    FDA found DuPont released Avicel excipient that failed conductivity limits, citing weak investigations and data integrity lapses.

    High risk
  37. Sagent Pharmaceuticals, Inc.

    FDA found SterRx, acquired by Sagent, made sterile drugs under conditions that risked contamination and lacked sterility assurance.

    High risk
  38. Centrient Pharmaceuticals India Private Limited

    Centrient Pharmaceuticals India's API plant drew FDA CGMP violations, including weak records and unproven beta-lactam contamination testing.

    High risk
  39. Kari Gran Inc.

    Kari Gran Inc. released OTC SPF sunscreen drugs without adequate batch testing or stability data.

    High risk
  40. AG Hair Limited

    FDA warned AG Hair Limited over CGMP failures for hand sanitizer drugs, including inadequate investigations, microbiological controls, and component testing.

    High risk
  41. Glenmark Pharmaceuticals Limited

    FDA cited Glenmark's Goa plant for poor investigations, weak process validation, lab data controls, and incomplete batch records.

    High risk
  42. Shuzy Rock Inc.

    FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

    High risk
  43. Omega & Delta Co., Inc.

    FDA says Omega & Delta's hand sanitizers were made under unsanitary conditions and with serious manufacturing quality failures.

    High risk
  44. Abraxis Bioscience LLC

    FDA warned Abraxis Bioscience about repeated contamination in media fills for sterile Abraxane at its Phoenix plant.

    High risk
  45. NatureLab Corp.

    FDA warned NatureLab Corp., a Carrollton, Texas dietary supplement maker, that its products are adulterated from CGMP violations and misbranded.

    Medium
  46. Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center, LLC

    FDA warned Nephron Sterile Compounding Center about insanitary sterile drug production and sterility assurance failures found in a 2022 inspection.

    High risk
  47. McConnell Labs Inc.

    McConnell Labs Inc. released hand sanitizers without raw material identity, finished product, or stability testing, FDA says.

    High risk
  48. Sovereign Pharmaceuticals, LLC

    FDA cited Sovereign Pharmaceuticals for manufacturing failures in bulk tablets, inadequate out-of-specification (OOS) investigations, quality-unit lapses, and an unapproved biological product.

    High risk
  49. Lupin Limited

    FDA warned Lupin Limited of current good manufacturing practice (CGMP) violations at its Tarapur API plant involving cleaning and genotoxic impurity controls.

    High risk
  50. Nephron SC Inc.

    Nephron SC's sterile drug manufacturing had unresolved cross-contamination and microbial contamination, making its drugs adulterated.

    High risk